Literature DB >> 16618119

The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy.

Isabel D Alves1, Diane Delaroche, Bernard Mouillac, Zdzislaw Salamon, Gordon Tollin, Victor J Hruby, Solange Lavielle, Sandrine Sagan.   

Abstract

Two nonstoichiometric ligand binding sites have been previously reported for the NK-1 receptor, with the use of classical methods (radioligand binding and second messenger assays). The most populated (major, NK-1M) binding site binds substance P (SP) and is related to the adenylyl cyclase pathway. The less populated (minor, NK-1m) binding site binds substance P, C-terminal hexa- and heptapeptide analogues of SP, and the NK-2 endogenous ligand, neurokinin A, and is coupled to the phospholipase C pathway. Here, we have examined these two binding sites with plasmon-waveguide resonance (PWR) spectroscopy that allows the thermodynamics and kinetics of ligand-receptor binding processes and the accompanying structural changes of the receptor to be monitored, through measurements of the anisotropic optical properties of lipid bilayers into which the receptor is incorporated. The binding of the three peptides, substance P, neurokinin A, and propionyl[Met(O(2))(11)]SP(7-11), to the partially purified NK-1 receptor has been analyzed by this method. Substance P and neurokinin A bind to the reconstituted receptor in a biphasic manner with two affinities (K(d1) = 0.14 +/- 0.02 nM and K(d2) = 1.4 +/- 0.18 nM, and K(d1) = 5.5 +/- 0.7 nM and K(d2) = 620 +/- 117 nM, respectively), whereas only one binding affinity (K(d) = 5.5 +/- 0.4 nM) could be observed for propionyl[Met(O(2))(11)]SP(7-11). Moreover, binding experiments in which one ligand was added after another one has been bound to the receptor have shown that the binding of these ligands to each binding site was unaffected by the fact that the other site was already occupied. These data strongly suggest that these two binding sites are independent and non-interconvertible on the time scale of these experiments (1-2 h).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618119      PMCID: PMC1865500          DOI: 10.1021/bi052586d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.

Authors:  S Sagan; J C Beaujouan; Y Torrens; M Saffroy; G Chassaing; J Glowinski; S Lavielle
Journal:  Mol Pharmacol       Date:  1997-07       Impact factor: 4.436

2.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

Authors:  M S Kramer; N Cutler; J Feighner; R Shrivastava; J Carman; J J Sramek; S A Reines; G Liu; D Snavely; E Wyatt-Knowles; J J Hale; S G Mills; M MacCoss; C J Swain; T Harrison; R G Hill; F Hefti; E M Scolnick; M A Cascieri; G G Chicchi; S Sadowski; A R Williams; L Hewson; D Smith; E J Carlson; R J Hargreaves; N M Rupniak
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

3.  Coupled plasmon-waveguide resonators: a new spectroscopic tool for probing proteolipid film structure and properties.

Authors:  Z Salamon; H A Macleod; G Tollin
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

4.  Agonist-specific receptor conformations.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1997-11       Impact factor: 14.819

Review 5.  The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles.

Authors:  L Quartara; C A Maggi
Journal:  Neuropeptides       Date:  1998-02       Impact factor: 3.286

Review 6.  The 'septide-sensitive' tachykinin receptor: still an enigma.

Authors:  J Glowinski
Journal:  Trends Pharmacol Sci       Date:  1995-11       Impact factor: 14.819

7.  Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11)]SP analogues.

Authors:  S Sagan; P Karoyan; G Chassaing; S Lavielle
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

8.  Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.

Authors:  S Sagan; G Chassaing; L Pradier; S Lavielle
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

9.  Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor.

Authors:  Sandrine Sagan; Jean Quancard; Olivier Lequin; Philippe Karoyan; Gérard Chassaing; Solange Lavielle
Journal:  Chem Biol       Date:  2005-05

10.  Coupled plasmon-waveguide resonance spectroscopy studies of the cytochrome b6f/plastocyanin system in supported lipid bilayer membranes.

Authors:  Z Salamon; D Huang; W A Cramer; G Tollin
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

View more
  7 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study.

Authors:  Isabel D Alves; Cherine Bechara; Astrid Walrant; Yefim Zaltsman; Chen-Yu Jiao; Sandrine Sagan
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

3.  Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).

Authors:  K Boyé; C Billottet; N Pujol; I D Alves; A Bikfalvi
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

4.  The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.

Authors:  Kevin Boyé; Nadège Pujol; Isabel D Alves; Ya-Ping Chen; Thomas Daubon; Yi-Zong Lee; Stephane Dedieu; Marion Constantin; Lorenzo Bello; Marco Rossi; Rolf Bjerkvig; Shih-Che Sue; Andreas Bikfalvi; Clotilde Billottet
Journal:  Nat Commun       Date:  2017-11-17       Impact factor: 14.919

Review 5.  The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.

Authors:  Agnieszka Majkowska-Pilip; Paweł Krzysztof Halik; Ewa Gniazdowska
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 6.  Plasmon Waveguide Resonance: Principles, Applications and Historical Perspectives on Instrument Development.

Authors:  Estelle Rascol; Sandrine Villette; Etienne Harté; Isabel D Alves
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411

7.  Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.

Authors:  Pierre Calmet; Monica De Maria; Etienne Harté; Daniel Lamb; Maria Serrano-Vega; Ali Jazayeri; Nuska Tschammer; Isabel D Alves
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.